NB003
NB003 Phase 1
Ningbo Newbay Technology Development · Phase 1 · Completed · Enrollment 258
| Arm | Reported safety |
|---|---|
| NB003, 2L to 4L or later | n/r |
| NB003, 3L subgroup | n/r |
A count stays a count. This page does not turn a count into a percent.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
NB003
Ningbo Newbay Technology Development · Phase 1 · Completed · Enrollment 258
| Arm | Reported safety |
|---|---|
| NB003, 2L to 4L or later | n/r |
| NB003, 3L subgroup | n/r |
A count stays a count. This page does not turn a count into a percent.